FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000MA8Q426

Market Closed - Börse Stuttgart 01:19:36 15/06/2024 am IST
13.03 EUR +0.77% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
Current month+3.74%
1 month+13.01%
Date Price Change
14/24/14 13.03 +0.77%
13/24/13 12.93 -2.93%
12/24/12 13.32 +1.37%
11/24/11 13.14 -1.13%
10/24/10 13.29 -0.30%

Delayed Quote Börse Stuttgart

Last update June 15, 2024 at 01:19 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MA8Q42
ISINDE000MA8Q426
Date issued 31/08/2021
Strike 171.5 $
Maturity Unlimited
Parity 12.35 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.35
Lowest since issue 5.12
Spread 0.04
Spread %0.30%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus